TAVR: a review of current practices and considerations in low‐risk patients

J Spears, Y Al-Saiegh, D Goldberg… - Journal of …, 2020 - Wiley Online Library
Transcatheter aortic valve replacement (TAVR) is an established treatment for severe,
symptomatic, aortic stenosis (AS) in patients of all risk categories and now comprises 12.5 …

Continuation versus interruption of oral anticoagulation during TAVI

DJ van Ginkel, WL Bor, HM Aarts… - … England Journal of …, 2025 - Mass Medical Soc
Background One third of patients undergoing transcatheter aortic-valve implantation (TAVI)
have an indication for oral anticoagulation owing to concomitant diseases. Interruption of …

[HTML][HTML] Cerebral embolic protection during transcatheter heart interventions

VAJ Diaz, SR Kapadia, A Linke, D Mylotte… - …, 2023 - pmc.ncbi.nlm.nih.gov
Stroke remains a devastating complication of transcatheter aortic valve replacement (TAVR),
with the incidence of clinically apparent stroke seemingly fixed at around 3% despite TAVR's …

[HTML][HTML] Cerebral embolic protection during transcatheter aortic-valve replacement

SR Kapadia, R Makkar, M Leon… - … England Journal of …, 2022 - Mass Medical Soc
Background Transcatheter aortic-valve replacement (TAVR) for the treatment of aortic
stenosis can lead to embolization of debris. Capture of debris by devices that provide …

Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II

TM Nazif, J Moses, R Sharma, A Dhoble, J Rovin… - Cardiovascular …, 2021 - jacc.org
Abstract Objectives The REFLECT II (Randomized Evaluation of TriGuard 3 Cerebral
Embolic Protection After Transcatheter Aortic Valve Implantation) trial was designed to …

Sex differences in transfemoral transcatheter aortic valve replacement

W Vlastra, J Chandrasekhar… - Journal of the American …, 2019 - jacc.org
Background: Transfemoral aortic valve replacement (TAVR) is a guideline-recommended
treatment option for patients with severe aortic valve stenosis. Women and men present with …

[HTML][HTML] Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT …

RK Kharbanda, AD Perkins, J Kennedy… - …, 2023 - ncbi.nlm.nih.gov
Transcatheter aortic valve implantation (TAVI) is an established treatment for aortic stenosis.
Cerebral embolic protection (CEP) devices may impact periprocedural stroke by capturing …

Cerebrovascular events in patients undergoing transfemoral transcatheter aortic valve implantation: a pooled patient‐level study

AC van Nieuwkerk, HM Aarts, KI Hemelrijk… - Journal of the …, 2024 - ahajournals.org
Background Cerebrovascular events remain one of the most devastating complications of
transcatheter aortic valve implantation (TAVI). Data from real‐world contemporary cohorts on …

[HTML][HTML] Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial

D Jagielak, R Targonski, C Frerker… - …, 2022 - ncbi.nlm.nih.gov
Background Stroke remains a feared complication associated with transcatheter aortic valve
implantation (TAVI). Embolic cerebral injury occurs in the majority of TAVI cases and can …

The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties

J Ten Berg, B Rocca, DJ Angiolillo… - European Heart …, 2022 - academic.oup.com
Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure, which is
used frequently in patients with symptomatic severe aortic valve stenosis. Most patients …